ctDNA for minimal disease research by hybridization capture in resected cancer samples
In this webinar, we explain how IDT's hybridization capture solutions are assisting researchers with overcoming challenges associated with circulating tumor DNA (ctDNA) for minimal residual disease (MRD) research. You will also gain insights about the importance of minimal residual disease research, how it compares to traditional methods, and the impact it is making with the discovery of new biomarkers. We hope by bringing these studies into the spotlight, it will foster new collaborations and discoveries within oncology research. Learn more at https://idtb.io/bmru7r
Watch video ctDNA for minimal disease research by hybridization capture in resected cancer samples online without registration, duration hours minute second in high quality. This video was added by user Integrated DNA Technologies (IDT) 19 April 2023, don't forget to share it with your friends and acquaintances, it has been viewed on our site 37 once and liked it people.